The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTotally Regulatory News (TLY)

Share Price Information for Totally (TLY)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 5.10
Bid: 4.70
Ask: 5.50
Change: 0.00 (0.00%)
Spread: 0.80 (17.021%)
Open: 5.10
High: 5.10
Low: 5.10
Prev. Close: 5.10
TLY Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

20 Mar 2017 13:15

RNS Number : 9689Z
Totally PLC
20 March 2017
 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

 

 

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii

Totally Plc

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

X

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

 

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

 

An event changing the breakdown of voting rights

X

Other (please specify):

 

 

3. Full name of person(s) subject to thenotification obligation: iii

Killik & Co LLP

4. Full name of shareholder(s) (if different from 3.):iv

Platform Securities

(on behalf of various discretionary clients of Killik & Co LLP)

5. Date of the transaction and date onwhich the threshold is crossed orreached: v

17th March 2017

6. Date on which issuer notified:

20th March 2017

7. Threshold(s) that is/are crossed orreached: vi, vii

Above 6%

      
 

 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

 

GBP Ord

GB00BYM1JJ00

Below 3%

Below 3%

3,222,727

3,222,727

 

6.20%

 

 

 

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate xiii

Exercise/Conversion Period xiv

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

 

 

 

 

 

 

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date xvii

Exercise/Conversion period xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 

 

 

 

 

 

 

Nominal

Delta

 

 

 

Total (A+B+C)

Number of voting rights

Percentage of voting rights

3,222,727

6.20%

                 
 

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi

 

 

 

Proxy Voting:

10. Name of the proxy holder:

 

11. Number of voting rights proxy holder will cease to hold:

 

12. Date on which proxy holder will cease to hold voting rights:

 

 

13. Additional information:

% held based on new issued share capital of 52,007,326

14. Contact name:

Heidi Richer

15. Contact telephone number:

020 7337 0400

   

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLOKKDDNBKDBNB
Date   Source Headline
9th Nov 20207:00 amRNSInterim results
2nd Nov 20207:00 amRNSNotice of Interim Results
14th Oct 20204:03 pmRNSHolding(s) in Company
13th Oct 20205:23 pmRNSReplacement: Holding(s) in Company
13th Oct 20202:09 pmRNSHolding(s) in Company
12th Oct 20207:00 amRNSHolding(s) in Company
2nd Oct 202012:22 pmRNSHolding(s) in Company
8th Sep 20204:30 pmRNSDirector/PDMR Notification
8th Sep 20208:54 amRNSHolding(s) in Company
7th Sep 20203:28 pmRNSResult of AGM
7th Sep 20207:00 amRNSAGM Statement and Trading Update
17th Aug 20207:00 amRNSContract Extensions and Pilot Worth c.£7.5 million
27th Jul 20207:00 amRNSHolding(s) in Company
27th Jul 20207:00 amRNSHolding(s) in Company
24th Jul 20203:02 pmRNSPosting of Annual Report and Accounts
24th Jul 202010:33 amRNSDirector/PDMR Shareholding
24th Jul 20209:21 amRNSHolding(s) in Company
23rd Jul 20204:27 pmRNSHolding(s) in Company
23rd Jul 202012:52 pmRNSDirector/PDMR Shareholding
22nd Jul 20204:09 pmRNSHolding(s) in Company
14th Jul 20206:09 pmRNSHolding(s) in Company
9th Jul 20204:07 pmRNSHolding(s) in Company
8th Jul 20207:00 amRNSInvestor Presentation - Preliminary Results
7th Jul 20207:00 amRNSPreliminary results
23rd Jun 20207:00 amRNSDirectorate Change
1st Jun 202010:20 amRNSDirector/PDMR notification
20th May 20204:41 pmRNSSecond Price Monitoring Extn
20th May 20204:36 pmRNSPrice Monitoring Extension
14th May 20207:00 amRNSVocare awarded significant contract extensions
13th May 20202:10 pmRNSHolding(s) in Company
12th May 202012:26 pmRNSHolding(s) in Company
6th May 20204:40 pmRNSSecond Price Monitoring Extn
6th May 20204:35 pmRNSPrice Monitoring Extension
6th May 20202:06 pmRNSSecond Price Monitoring Extn
6th May 20202:00 pmRNSPrice Monitoring Extension
5th May 20205:47 pmRNSHolding(s) in Company
5th May 20202:38 pmRNSProposed purchase of Ordinary Shares
4th May 20202:44 pmRNSHolding(s) in Company
23rd Apr 20201:21 pmRNSHolding(s) in Company
20th Apr 20207:00 amRNSTrading Update
27th Mar 202011:05 amRNSSecond Price Monitoring Extn
27th Mar 202011:00 amRNSPrice Monitoring Extension
27th Mar 20207:00 amRNSUpdate on COVID-19
3rd Mar 20202:06 pmRNSSecond Price Monitoring Extn
3rd Mar 20202:00 pmRNSPrice Monitoring Extension
7th Feb 20202:05 pmRNSSecond Price Monitoring Extn
7th Feb 20202:00 pmRNSPrice Monitoring Extension
7th Feb 202010:04 amRNSAbout Health: Key new £8.4m contract in Manchester
22nd Jan 20207:00 amRNSDividend Declaration
6th Jan 20206:29 pmRNSGrant of Options under SAYE Option Scheme

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.